408 related articles for article (PubMed ID: 30931530)
1. Toward understanding tissue-specific symptoms in dolichol-phosphate-mannose synthesis disorders; insight from DPM3-CDG.
van Tol W; Michelakakis H; Georgiadou E; van den Bergh P; Moraitou M; Papadimas GK; Papadopoulos C; Huijben K; Alsady M; Willemsen MA; Lefeber DJ
J Inherit Metab Dis; 2019 Sep; 42(5):984-992. PubMed ID: 30931530
[TBL] [Abstract][Full Text] [Related]
2. Congenital disorder of glycosylation due to DPM1 mutations presenting with dystroglycanopathy-type congenital muscular dystrophy.
Yang AC; Ng BG; Moore SA; Rush J; Waechter CJ; Raymond KM; Willer T; Campbell KP; Freeze HH; Mehta L
Mol Genet Metab; 2013 Nov; 110(3):345-351. PubMed ID: 23856421
[TBL] [Abstract][Full Text] [Related]
3. A mutation in mannose-phosphate-dolichol utilization defect 1 reveals clinical symptoms of congenital disorders of glycosylation type I and dystroglycanopathy.
van Tol W; Ashikov A; Korsch E; Abu Bakar N; Willemsen MA; Thiel C; Lefeber DJ
JIMD Rep; 2019 Nov; 50(1):31-39. PubMed ID: 31741824
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of Dol-P-Man synthase subunit DPM3 bridges the congenital disorders of glycosylation with the dystroglycanopathies.
Lefeber DJ; Schönberger J; Morava E; Guillard M; Huyben KM; Verrijp K; Grafakou O; Evangeliou A; Preijers FW; Manta P; Yildiz J; Grünewald S; Spilioti M; van den Elzen C; Klein D; Hess D; Ashida H; Hofsteenge J; Maeda Y; van den Heuvel L; Lammens M; Lehle L; Wevers RA
Am J Hum Genet; 2009 Jul; 85(1):76-86. PubMed ID: 19576565
[TBL] [Abstract][Full Text] [Related]
5. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
[TBL] [Abstract][Full Text] [Related]
6. Dilated cardiomyopathy and limb-girdle muscular dystrophy-dystroglycanopathy due to novel pathogenic variants in the DPM3 gene.
Svahn J; Laforêt P; Vial C; Streichenberger N; Romero N; Bouchet-Séraphin C; Bruneel A; Dupré T; Seta N; Menassa R; Michel-Calemard L; Stojkovic T
Neuromuscul Disord; 2019 Jul; 29(7):497-502. PubMed ID: 31266720
[TBL] [Abstract][Full Text] [Related]
7. A homozygous DPM3 mutation in a patient with alpha-dystroglycan-related limb girdle muscular dystrophy.
Van den Bergh PYK; Sznajer Y; Van Parys V; van Tol W; Wevers RA; Lefeber DJ; Xu L; Lek M; MacArthur DG; Johnson K; Phillips L; Töpf A; Straub V
Neuromuscul Disord; 2017 Nov; 27(11):1043-1046. PubMed ID: 28803818
[TBL] [Abstract][Full Text] [Related]
8. Dolichol-phosphate mannose synthase depletion in zebrafish leads to dystrophic muscle with hypoglycosylated α-dystroglycan.
Marchese M; Pappalardo A; Baldacci J; Verri T; Doccini S; Cassandrini D; Bruno C; Fiorillo C; Garcia-Gil M; Bertini E; Pitto L; Santorelli FM
Biochem Biophys Res Commun; 2016 Aug; 477(1):137-143. PubMed ID: 27291147
[TBL] [Abstract][Full Text] [Related]
9. Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan.
Carss KJ; Stevens E; Foley AR; Cirak S; Riemersma M; Torelli S; Hoischen A; Willer T; van Scherpenzeel M; Moore SA; Messina S; Bertini E; Bönnemann CG; Abdenur JE; Grosmann CM; Kesari A; Punetha J; Quinlivan R; Waddell LB; Young HK; Wraige E; Yau S; Brodd L; Feng L; Sewry C; MacArthur DG; North KN; Hoffman E; Stemple DL; Hurles ME; van Bokhoven H; Campbell KP; Lefeber DJ; ; Lin YY; Muntoni F
Am J Hum Genet; 2013 Jul; 93(1):29-41. PubMed ID: 23768512
[TBL] [Abstract][Full Text] [Related]
10. A recurrent homozygous missense DPM3 variant leads to muscle and brain disease.
Nagy S; Lau T; Alavi S; Karimiani EG; Vallian J; Ng BG; Noroozi Asl S; Akhondian J; Bahreini A; Yaghini O; Uapinyoying P; Bonnemann C; Freeze HH; Dissanayake VHW; Sirisena ND; Schmidts M; Houlden H; Moreno-De-Luca A; Maroofian R
Clin Genet; 2022 Dec; 102(6):530-536. PubMed ID: 35932216
[TBL] [Abstract][Full Text] [Related]
11. Guanosine diphosphate-mannose:GlcNAc2-PP-dolichol mannosyltransferase deficiency (congenital disorders of glycosylation type Ik): five new patients and seven novel mutations.
Dupré T; Vuillaumier-Barrot S; Chantret I; Sadou Yayé H; Le Bizec C; Afenjar A; Altuzarra C; Barnérias C; Burglen L; de Lonlay P; Feillet F; Napuri S; Seta N; Moore SE
J Med Genet; 2010 Nov; 47(11):729-35. PubMed ID: 20679665
[TBL] [Abstract][Full Text] [Related]
12. Synergistic use of glycomics and single-molecule molecular inversion probes for identification of congenital disorders of glycosylation type-1.
Abu Bakar N; Ashikov A; Brum JM; Smeets R; Kersten M; Huijben K; Keng WT; Speck-Martins CE; de Carvalho DR; de Rizzo IMPO; de Mello WD; Heiner-Fokkema R; Gorman K; Grunewald S; Michelakakis H; Moraitou M; Martinelli D; van Scherpenzeel M; Janssen M; de Boer L; van den Heuvel LP; Thiel C; Lefeber DJ
J Inherit Metab Dis; 2022 Jul; 45(4):769-781. PubMed ID: 35279850
[TBL] [Abstract][Full Text] [Related]
13. A new intronic mutation in the DPM1 gene is associated with a milder form of CDG Ie in two French siblings.
Dancourt J; Vuillaumier-Barrot S; de Baulny HO; Sfaello I; Barnier A; le Bizec C; Dupre T; Durand G; Seta N; Moore SE
Pediatr Res; 2006 Jun; 59(6):835-9. PubMed ID: 16641202
[TBL] [Abstract][Full Text] [Related]
14. Dolichol phosphate mannose synthase (DPM1) mutations define congenital disorder of glycosylation Ie (CDG-Ie).
Kim S; Westphal V; Srikrishna G; Mehta DP; Peterson S; Filiano J; Karnes PS; Patterson MC; Freeze HH
J Clin Invest; 2000 Jan; 105(2):191-8. PubMed ID: 10642597
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
[TBL] [Abstract][Full Text] [Related]
16. ALG12-CDG: novel glycophenotype insights endorse the molecular defect.
Sturiale L; Bianca S; Garozzo D; Terracciano A; Agolini E; Messina A; Palmigiano A; Esposito F; Barone C; Novelli A; Fiumara A; Jaeken J; Barone R
Glycoconj J; 2019 Dec; 36(6):461-472. PubMed ID: 31529350
[TBL] [Abstract][Full Text] [Related]
17. Genetic defects in dolichol metabolism.
Buczkowska A; Swiezewska E; Lefeber DJ
J Inherit Metab Dis; 2015 Jan; 38(1):157-69. PubMed ID: 25270028
[TBL] [Abstract][Full Text] [Related]
18. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
[TBL] [Abstract][Full Text] [Related]
19. ALG1-CDG: a new case with early fatal outcome.
Rohlfing AK; Rust S; Reunert J; Tirre M; Du Chesne I; Wemhoff S; Meinhardt F; Hartmann H; Das AM; Marquardt T
Gene; 2014 Jan; 534(2):345-51. PubMed ID: 24157261
[TBL] [Abstract][Full Text] [Related]
20. Aberrant glycosylation of alpha-dystroglycan and congenital muscular dystrophies.
Endo T
Acta Myol; 2005 Oct; 24(2):64-9. PubMed ID: 16550917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]